Zobrazeno 1 - 10
of 46
pro vyhledávání: '"Melissa Prah"'
Autor:
Mark S. Shiroishi, Dane Weinert, Steven Y. Cen, Bino Varghese, Timothy Dondlinger, Melissa Prah, Jesse Mendoza, Sina Nazemi, Nima Ameli, Negin Amini, Salman Shohas, Shannon Chen, Bavrina Bigjahan, Gabriel Zada, Thomas Chen, Josh Neman-Ebrahim, Eric L. Chang, Frances E. Chow, Zhaoyang Fan, Wensha Yang, Frank J. Attenello, Jason Ye, Paul E. Kim, Vishal N. Patel, Alexander Lerner, Jay Acharya, Leland S. Hu, C. Chad Quarles, Jerrold L. Boxerman, Ona Wu, Kathleen M. Schmainda
Publikováno v:
Frontiers in Oncology, Vol 13 (2023)
Introduction1.5 Tesla (1.5T) remain a significant field strength for brain imaging worldwide. Recent computer simulations and clinical studies at 3T MRI have suggested that dynamic susceptibility contrast (DSC) MRI using a 30° flip angle (“low-FA
Externí odkaz:
https://doaj.org/article/a7bc0151dca8406688b76c2a967c274a
Autor:
Eva-Maria Ratai, Zheng Zhang, James Fink, Mark Muzi, Lucy Hanna, Erin Greco, Todd Richards, Daniel Kim, Ovidiu C Andronesi, Akiva Mintz, Lale Kostakoglu, Melissa Prah, Benjamin Ellingson, Kathleen Schmainda, Gregory Sorensen, Daniel Barboriak, David Mankoff, Elizabeth R Gerstner, ACRIN 6684 trial group
Publikováno v:
PLoS ONE, Vol 13, Iss 6, p e0198548 (2018)
A multi-center imaging trial by the American College of Radiology Imaging Network (ACRIN) "A Multicenter, phase II assessment of tumor hypoxia in glioblastoma using 18F Fluoromisonidazole (FMISO) with PET and MRI (ACRIN 6684)", was conducted to asses
Externí odkaz:
https://doaj.org/article/82531403d7ea48b78564101715f30dcd
Autor:
David A. Mankoff, Daniel P. Barboriak, A. Gregory Sorensen, Eva-Maria Ratai, Benjamin M. Ellingson, Edward A. Eikman, Lale Kostakoglu, Akiva Mintz, Kathleen M. Schmainda, Melissa Prah, Erin Greco, Lucy Hanna, Mark Muzi, James R. Fink, Zheng Zhang, Elizabeth R. Gerstner
Purpose: Structural and functional alterations in tumor vasculature are thought to contribute to tumor hypoxia which is a primary driver of malignancy through its negative impact on the efficacy of radiation, immune surveillance, apoptosis, genomic s
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::683e1253757de96785d22b07f65d76d2
https://doi.org/10.1158/1078-0432.c.6524310.v1
https://doi.org/10.1158/1078-0432.c.6524310.v1
Autor:
David A. Mankoff, Daniel P. Barboriak, A. Gregory Sorensen, Eva-Maria Ratai, Benjamin M. Ellingson, Edward A. Eikman, Lale Kostakoglu, Akiva Mintz, Kathleen M. Schmainda, Melissa Prah, Erin Greco, Lucy Hanna, Mark Muzi, James R. Fink, Zheng Zhang, Elizabeth R. Gerstner
Supplemental Table 1: Participating centers that enrolled patients; Supplemental Table 2: Serial FMISO PET Imaging.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8436f1655db0bede1eaeb4f6a8d1c061
https://doi.org/10.1158/1078-0432.22459785
https://doi.org/10.1158/1078-0432.22459785
Autor:
Sarah Kohn, Melissa Prah, Min Kong, Daniel Phung, Javier Urcuyo, Jason Ye, Frank Attenello, Jesse Mendoza, Mark Shiroishi, Leland Hu, Kathleen Schmainda
Publikováno v:
Neuro-Oncology. 24:vii163-vii164
INTRODUCTION DSC-MRI perfusion methods are commonly used to evaluate both primary and metastatic brain cancer with the creation of maps of relative cerebral blood volume (rCBV). Recently, guidelines were established to ensure a standard DSC-MRI acqui
Autor:
Kathleen M. Schmainda, Scott D. Rand, Wade M. Mueller, Malika Siker, Christopher J. Schultz, Cathy S. Marszalkowski, Melissa Prah, Amber A. Retzlaff, Joseph Bovi, Jennifer Connelly
Publikováno v:
International journal of radiation oncology, biology, physics
Purpose: Dismal prognosis and limited treatment options for recurrent high-grade glioma have provoked interest in various forms of reirradiation. Pulsed reduced dose rate radiation therapy (pRDR) is a promising technique that exploits low-dose hyper-
Autor:
Melissa Prah, Daniel P. Barboriak, Kathleen M. Schmainda, Eunhee Kim, Jerrold L. Boxerman, Helga S. Marques
Publikováno v:
Neuro Oncol
Background In Radiation Therapy Oncology Group (RTOG) 0825, a phase III trial of standard therapy with bevacizumab or without (placebo) in newly diagnosed glioblastoma, 44 patients underwent dynamic contrast enhanced (DCE) and/or dynamic susceptibili
Autor:
Kurt Li, William A. See, David A. Hormuth, Wei Huang, Michael Brehler, Yuan Li, Savannah Duenweg, Amita Shukla-Dave, Daekeun You, Eve LoCastro, Keith Mcleod Hulsey, Andrey Fedorov, John D. Bukowy, Ananth J. Madhuranthakam, Mark Muzi, Laura C. Bell, Kenneth Jacobsohn, Yue Cao, Thomas L. Chenevert, Tatjana Antic, Kenneth A. Iczkowski, Sarah L. Hurrell, Kathleen M. Schmainda, Petar Duvnjak, Anjishnu Banerjee, Mark Hohenwalter, Allison K. Lowman, Gladell P. Paner, Michael A. Jacobs, Dariya I. Malyarenko, Yousef Mazaheri, Samuel Bobholz, Marja T. Nevalainen, Peter S. LaViolette, Watchareepohn Palangmonthip, Thomas E. Yankeelov, Stefanie J. Hectors, C. Chad Quarles, Meiyappan Solaiyappan, Michael Griffin, Bachir Taouli, Sean D. McGarry, Melissa Prah
Publikováno v:
Journal of magnetic resonance imaging : JMRI. 55(6)
BACKGROUND Diffusion-weighted imaging (DWI) is commonly used to detect prostate cancer, and a major clinical challenge is differentiating aggressive from indolent disease. PURPOSE To compare 14 site-specific parametric fitting implementations applied
Publikováno v:
Neuro-Oncology. 24:vii171-vii171
Dynamic susceptibility contrast (DSC) perfusion MRI (pMRI) has proven efficacy in the evaluation of glioma grade, progression and response to therapy. While not currently integrated within RANO (Response Assessment in Neuro Oncology) criteria, pMRI i
Autor:
Mona Al-Gizawiy, Robert Wujek, Melissa Prah, Jennifer Connelly, Christopher Chitambar, Kathleen Schmainda
Publikováno v:
Neuro-Oncology. 24:vii212-vii212
BACKGROUND We previously reported on our in vitro and in vivo studies using the metallocompound gallium maltolate (GaM) to target glioblastoma (GBM). We demonstrated a profound cytotoxic effect in vitrov and in vivo. Additionally, our preliminary in